Modus Therapeutics Holding AB (publ) (STO:MODTX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
+0.0060 (2.04%)
Jan 21, 2026, 4:20 PM CET
-78.87%
Market Cap35.76M
Revenue (ttm)n/a
Net Income (ttm)-17.94M
Shares Out121.63M
EPS (ttm)-0.44
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume520,964
Average Volume489,433
Open0.2690
Previous Close0.2940
Day's Range0.2690 - 0.3180
52-Week Range0.2650 - 5.0000
Beta0.22
RSI46.31
Earnings DateFeb 25, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol MODTX
Full Company Profile

Financial Performance

Financial Statements